U.S., Aug. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07780045) titled 'SII and SIRI as Prognostic Biomarkers in Lupus Nephritis' on Aug. 19.
Brief Summary: This prospective observational study aims to evaluate the prognostic utility of the Systemic Immune-Inflammation Index (SII) and Systemic Inflammation Response Index (SIRI) as novel inflammatory biomarkers for monitoring disease activity and predicting renal progression, flares, and outcomes in patients with lupus nephritis.
Study Start Date: Aug. 19
Study Type: OBSERVATIONAL
Condition:
Lupus Nephritis
Systemic Lupus Erythematosus
Kidney Diseases
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Assiut University
Information provided by (Respon...